ZA896851B - Use of ace-inhibitors - Google Patents

Use of ace-inhibitors

Info

Publication number
ZA896851B
ZA896851B ZA896851A ZA896851A ZA896851B ZA 896851 B ZA896851 B ZA 896851B ZA 896851 A ZA896851 A ZA 896851A ZA 896851 A ZA896851 A ZA 896851A ZA 896851 B ZA896851 B ZA 896851B
Authority
ZA
South Africa
Prior art keywords
vessel
prevention
ace
inhibitors
neointima
Prior art date
Application number
ZA896851A
Other languages
English (en)
Inventor
Hans Rudolf Baumgartner
Rudolf Baumgartner Hans
Jean-Paul Clozel
Clozel Jean-Paul
Fridolin Hefti
Hefti Fridolin
Markus Hosang
Hosang Markus
Herbert Kuhn
Kuhn Herbert
Rita Mueller
Mueller Rita
Jerry Powell
Powell Jerry
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA896851B publication Critical patent/ZA896851B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Prostheses (AREA)
ZA896851A 1988-09-14 1989-09-07 Use of ace-inhibitors ZA896851B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH342188 1988-09-14

Publications (1)

Publication Number Publication Date
ZA896851B true ZA896851B (en) 1990-06-27

Family

ID=4255625

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896851A ZA896851B (en) 1988-09-14 1989-09-07 Use of ace-inhibitors

Country Status (13)

Country Link
EP (1) EP0363671B1 (pt)
JP (1) JPH02121922A (pt)
KR (1) KR900004337A (pt)
AT (1) ATE100716T1 (pt)
AU (1) AU625693B2 (pt)
DE (1) DE58906814D1 (pt)
DK (1) DK452089A (pt)
ES (1) ES2061853T3 (pt)
HU (1) HU206186B (pt)
IE (1) IE892931L (pt)
IL (1) IL91572A (pt)
PT (1) PT91705B (pt)
ZA (1) ZA896851B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3925759A1 (de) * 1989-08-03 1991-02-07 Thera Patent Verwaltungs Gmbh Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe
DE3926606A1 (de) * 1989-08-11 1991-02-14 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
CA2042159A1 (en) * 1990-05-31 1991-12-01 Miguel A. Ondetti Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
DK0682947T3 (da) 1994-05-19 1998-05-04 Mitsubishi Chem Corp Medikament til terapeutisk og profylaktisk behandling af sygdomme forårsaget af glatmuskelcelle-hyperplasi
JPH10508034A (ja) * 1995-03-24 1998-08-04 モレキュメティックス リミテッド βシート模倣物および生物学的に活性なペプチドまたはタンパク質のインヒビターとしてのその使用
ES2201266T3 (es) * 1996-01-17 2004-03-16 Taiho Pharmaceutical Company Limited Inhibidores del espesamiento de la capa intima.
EP1611886A3 (en) * 1999-08-30 2008-06-04 Sanofi-Aventis Deutschland GmbH Inhibitors of the renin-angiotensin system for the prevention of cardiovascular disorders
JP4904859B2 (ja) * 2006-03-13 2012-03-28 大日本印刷株式会社 印刷ユニットおよびドクターブレードの研磨方法
MX2009000358A (es) * 2006-07-10 2009-01-27 Teva Pharma Formulacion estable que comprende una combinacion de un farmaco sensible a la humedad y un segundo farmaco y procedimiento de fabricacion de ella.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
AT377496B (de) 1981-06-19 1985-03-25 Voith Gmbh J M Vorrichtung zum anwickeln einer warenbahn auf eine neu eingelegte wickelhuelse in einer doppeltragwalzen-wickelmaschine

Also Published As

Publication number Publication date
IL91572A (en) 1994-01-25
HUT51148A (en) 1990-04-28
PT91705A (pt) 1990-03-30
DK452089A (da) 1990-03-15
KR900004337A (ko) 1990-04-12
EP0363671A3 (de) 1991-12-11
JPH02121922A (ja) 1990-05-09
AU625693B2 (en) 1992-07-16
IL91572A0 (en) 1990-04-29
DK452089D0 (da) 1989-09-13
DE58906814D1 (de) 1994-03-10
PT91705B (pt) 1995-05-31
IE892931L (en) 1990-03-14
ATE100716T1 (de) 1994-02-15
HU206186B (en) 1992-09-28
ES2061853T3 (es) 1994-12-16
EP0363671A2 (de) 1990-04-18
EP0363671B1 (de) 1994-01-26
AU4124089A (en) 1990-03-22

Similar Documents

Publication Publication Date Title
ZA896851B (en) Use of ace-inhibitors
IE893123L (en) Use of gamma-interferon for the treatment of vascular¹stenosis
HUP9802093A3 (en) Use of nitrogen-monoxyde for producing medicament useful for treatment of vascular thrombosis and restenosis
ATE406909T1 (de) Prävention und behandlung von pathologien, die mit einer abnormalen proliferationglatter muskelzellen verbunden sind
NO861624L (no) Roerformet proteseartikkel.
AU2793189A (en) Improved vascular dilation catheter construction
EP1649853A3 (en) Microtubule stabilizing agents for treating atherosclerosis or restenosis
NO992769D0 (no) FremgangsmÕte for behandling og forhindring av hjertesvikt og ventricular dilasjon
ATE253076T1 (de) Antithrombosemittel
AU5537994A (en) Therapeutic treatment for inhibiting vascular restenosis
AU6178094A (en) Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
ATE216888T1 (de) Desferri-exochelin zur behandlung von atherosclerose und gefässbeschädigung durch verhinderung der proliferation von glatten muskelzellen
ATE164521T1 (de) Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose
NO924637L (no) Fremgangsmaate ved forhindring av gjentilstopping av arterier
EP0661981A1 (en) USE OF HYALURONIC ACID AND DERIVATIVES TO PREVENT ARTERIAL RESTENOSIS.
EP0407229A3 (en) Laser catheter apparatus for use in arteries or other narrow paths within living organisms
Elbert et al. Endoluminal stent coatings consisting of adsorbing copolymers reduce neointimal hyperplasia in the pig
CS846287A1 (en) Aid for vascular prostheses treatment of venous origin
FR2669826B1 (fr) Catheter pour la dilatation des arteres.
IT228470Y1 (it) Catetere per la disostruzione delle arterie
GB9016609D0 (en) Compositions for the active or prophylactic treatment of intravascular coagulation or thrombosis
BG101472A (en) Vascular transplant and method for its preparation